Data spanning the past 90 days through February 19, 2026 reveals that Eledon Pharmaceuticals's three principal insider shareholders consist of TenPercentOwner Partners L P/Il Bvf (220.46K shares), Chief Financial Officer Paul Sean Little (10.00K shares), Chief Executive Officer David-Alexandre C Gros (9.00K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Partners L P/Il Bvf | 220,460 | 13 May, 2024 | |
| Paul Sean Little | Chief Financial Officer | 10,000 | 14 Jun, 2021 |
| David-Alexandre C Gros | Chief Executive Officer | 9,000 | 21 Dec, 2021 |
| Keith Katkin | 8,575 | 16 Jan, 2026 | |
| Jan Hillson | 3,430 | 16 Jan, 2026 | |
| Allan Kirk | 3,430 | 16 Jan, 2026 | |
| John S. Mcbride | 3,430 | 16 Jan, 2026 | |
| June Lee | 3,430 | 16 Jan, 2026 | |
| James A. Jr. Robinson | 3,430 | 16 Jan, 2026 | |
| Steven Perrin | President | 1,000 | 23 Nov, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 10 Jan, 2026 | Keith Katkin | Common Stock | A | 8,575 | $0.00 | 8,575 | D | M |
| 10 Jan, 2026 | John S. Mcbride | Common Stock | A | 3,430 | $0.00 | 3,430 | D | M |
| 10 Jan, 2026 | June Lee | Common Stock | A | 3,430 | $0.00 | 3,430 | D | M |
| 10 Jan, 2026 | James A. Jr. Robinson | Common Stock | A | 3,430 | $0.00 | 3,430 | D | M |
| 10 Jan, 2026 | Jan Hillson | Common Stock | A | 3,430 | $0.00 | 3,430 | D | M |
| 10 Jan, 2026 | Allan Kirk | Common Stock | A | 3,430 | $0.00 | 3,430 | D | M |
| 09 May, 2024 | Partners L P/Il Bvf | Common Stock, $0.001 par value | A | 75,431 | - | 220,460 | D | P |
| 09 May, 2024 | Partners L P/Il Bvf | - | - | 220,460 | D | |||
| 09 May, 2024 | Partners L P/Il Bvf | Common Stock, $0.001 par value | A | 821,121 | - | 2,633,679 | D | P |
| 09 May, 2024 | Partners L P/Il Bvf | - | - | 2,633,679 | D | |||
| 09 May, 2024 | Partners L P/Il Bvf | - | - | 3,361,803 | D | |||
| 09 May, 2024 | Partners L P/Il Bvf | Common Stock, $0.001 par value | A | 1,031,385 | - | 3,361,803 | D | P |
| 05 May, 2023 | Partners L P/Il Bvf | Common Stock, $0.001 par value | A | 837,146 | - | 1,812,558 | D | P |
| 05 May, 2023 | Partners L P/Il Bvf | Common Stock, $0.001 par value | A | 1,055,445 | - | 2,330,418 | D | P |
| 05 May, 2023 | Partners L P/Il Bvf | Common Stock, $0.001 par value | A | 86,341 | - | 145,029 | D | P |
| 23 Nov, 2022 | Steven Perrin | Common Stock | A | 1,000 | $2.60 | 1,000 | D | P |
| 23 Nov, 2022 | Steven Perrin | - | - | 1,000 | D | |||
| 20 Dec, 2021 | David-Alexandre C Gros | - | - | 9,000 | D | |||
| 20 Dec, 2021 | David-Alexandre C Gros | Common Stock | A | 2,000 | $4.48 | 9,000 | D | P |
| 17 Aug, 2021 | David-Alexandre C Gros | Common Stock | A | 4,000 | $6.21 | 7,000 | D | P |